$FF
FutureFuel Corp.

2017 Q3 Form 10-Q Financial Statement

#000143774917018882 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $77.61M $69.31M
YoY Change 11.98% -35.26%
Cost Of Revenue $61.09M $54.17M
YoY Change 12.77% -44.14%
Gross Profit $5.526M $10.32M
YoY Change -46.45% 18.95%
Gross Profit Margin 7.12% 14.89%
Selling, General & Admin $1.400M $1.800M
YoY Change -22.22% -10.0%
% of Gross Profit 25.33% 17.44%
Research & Development $935.0K $688.0K
YoY Change 35.9% -6.78%
% of Gross Profit 16.92% 6.67%
Depreciation & Amortization $2.930M $2.700M
YoY Change 8.52% 3.45%
% of Gross Profit 53.02% 26.17%
Operating Expenses $2.326M $2.478M
YoY Change -6.13% -9.63%
Operating Profit $3.200M $7.841M
YoY Change -59.19% 32.16%
Interest Expense $43.00K $45.00K
YoY Change -4.44% 7.14%
% of Operating Profit 1.34% 0.57%
Other Income/Expense, Net $1.864M $1.159M
YoY Change 60.83% 18.63%
Pretax Income $5.064M $9.000M
YoY Change -43.73% 30.25%
Income Tax $1.730M -$3.868M
% Of Pretax Income 34.16% -42.98%
Net Earnings $3.334M $12.87M
YoY Change -74.09% 165.32%
Net Earnings / Revenue 4.3% 18.57%
Basic Earnings Per Share $0.08 $0.29
Diluted Earnings Per Share $0.08 $0.29
COMMON SHARES
Basic Shares Outstanding 43.71M 43.57M
Diluted Shares Outstanding 43.71M 43.57M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $223.9M $286.5M
YoY Change -21.84% 16.6%
Cash & Equivalents $113.2M $182.4M
Short-Term Investments $110.7M $104.1M
Other Short-Term Assets $1.467M $1.052M
YoY Change 39.45% -71.44%
Inventory $43.52M $47.95M
Prepaid Expenses $542.0K $538.0K
Receivables $21.28M $29.99M
Other Receivables $15.00M $15.30M
Total Short-Term Assets $320.3M $388.4M
YoY Change -17.52% 23.24%
LONG-TERM ASSETS
Property, Plant & Equipment $111.8M $119.2M
YoY Change -6.19% -5.25%
Goodwill
YoY Change
Intangibles $1.408M $1.408M
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $3.839M $3.733M
YoY Change 2.84% 26.03%
Total Long-Term Assets $117.2M $124.7M
YoY Change -5.95% -4.58%
TOTAL ASSETS
Total Short-Term Assets $320.3M $388.4M
Total Long-Term Assets $117.2M $124.7M
Total Assets $437.6M $513.0M
YoY Change -14.71% 15.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.22M $24.59M
YoY Change -1.48% 31.57%
Accrued Expenses $4.072M $6.541M
YoY Change -37.75% -4.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $42.21M $41.30M
YoY Change 2.21% 25.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.396M $2.999M
YoY Change 13.24% 85.93%
Total Long-Term Liabilities $49.65M $44.25M
YoY Change 12.21% -6.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.21M $41.30M
Total Long-Term Liabilities $49.65M $44.25M
Total Liabilities $91.86M $85.54M
YoY Change 7.38% 6.82%
SHAREHOLDERS EQUITY
Retained Earnings $55.75M $142.8M
YoY Change -60.97% 66.07%
Common Stock $4.000K $4.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $345.7M $427.5M
YoY Change
Total Liabilities & Shareholders Equity $437.6M $513.0M
YoY Change -14.71% 15.09%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $3.334M $12.87M
YoY Change -74.09% 165.32%
Depreciation, Depletion And Amortization $2.930M $2.700M
YoY Change 8.52% 3.45%
Cash From Operating Activities $8.480M $30.85M
YoY Change -72.51% 23.1%
INVESTING ACTIVITIES
Capital Expenditures -$920.0K -$860.0K
YoY Change 6.98% -48.5%
Acquisitions
YoY Change
Other Investing Activities -$2.550M -$18.55M
YoY Change -86.25% -233.55%
Cash From Investing Activities -$3.480M -$19.40M
YoY Change -82.06% -258.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.770M -2.670M
YoY Change 3.75% -13.59%
NET CHANGE
Cash From Operating Activities 8.480M 30.85M
Cash From Investing Activities -3.480M -19.40M
Cash From Financing Activities -2.770M -2.670M
Net Change In Cash 2.230M 8.780M
YoY Change -74.6% -74.32%
FREE CASH FLOW
Cash From Operating Activities $8.480M $30.85M
Capital Expenditures -$920.0K -$860.0K
Free Cash Flow $9.400M $31.71M
YoY Change -70.36% 18.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
CY2016Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
142000
CY2017Q3 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
4072000
CY2016Q4 ff Accrued Expenses And Other Currentliabilities
AccruedExpensesAndOtherCurrentliabilities
2485000
CY2017Q3 ff Blending Tax Credit
BlendingTaxCredit
0
CY2016Q4 ff Blending Tax Credit
BlendingTaxCredit
5495000
ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
60000
ff Change In Fair Value Of Derivative Instruments And Marketable Securities
ChangeInFairValueOfDerivativeInstrumentsAndMarketableSecurities
-6686000
CY2017Q3 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
9880000
CY2016Q3 ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
3384000
ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
17995000
ff Cost Of Goods Sold Related Parties
CostOfGoodsSoldRelatedParties
6819000
CY2017Q3 ff Distribution Related Parties
DistributionRelatedParties
40000
CY2016Q3 ff Distribution Related Parties
DistributionRelatedParties
127000
ff Distribution Related Parties
DistributionRelatedParties
117000
ff Distribution Related Parties
DistributionRelatedParties
340000
ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
-31000
ff Excess Tax Benefit Expense From Sharebased Compensation Financing Activities
ExcessTaxBenefitExpenseFromSharebasedCompensationFinancingActivities
-183000
ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-142000
ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
4000
ff Increase Decrease Prepaid Expenses Related Parties
IncreaseDecreasePrepaidExpensesRelatedParties
-35000
CY2017Q3 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
16000
CY2016Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000
CY2017Q3 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
77106000
CY2016Q3 ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
66893000
ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
198726000
ff Sales Revenue Net Excluding Revenue From Related Parties
SalesRevenueNetExcludingRevenueFromRelatedParties
175939000
CY2017Q3 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
3000
CY2016Q3 ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
35000
ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
15000
ff Undistributed Earnings Loss Reallocated To Participating Securities
UndistributedEarningsLossReallocatedToParticipatingSecurities
131000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24224000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22799000
CY2017Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
4034000
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1254000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21278000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24359000
CY2017Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
1566000
CY2016Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
385000
CY2017Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1078000
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1428000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4072000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2627000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8152000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3540000
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281813000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281087000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
109000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
108000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76667
us-gaap Asset Impairment Charges
AssetImpairmentCharges
28000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
178000
CY2017Q3 us-gaap Assets
Assets
437571000
CY2016Q4 us-gaap Assets
Assets
529043000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
320331000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
405282000
CY2017Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
117240000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
123761000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
16854000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
31126000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2017Q3 us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
26000
CY2016Q3 us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
-322000
us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
-543000
us-gaap Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
-727000
CY2017Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3314000
CY2016Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
803000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113245000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
199272000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154049000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
182373000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-86027000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28324000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43741670
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43749970
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43741670
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43749970
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3987000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13750000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12176000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39860000
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
61088000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
54170000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
165469000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
144446000
CY2017Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2016Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
144000
CY2017Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
216000
CY2016Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
325000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1303000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9243000
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6100000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5530000
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13002000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16792000
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
33252000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
32064000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8735000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7960000
CY2017Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-198000
CY2016Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-258000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9000000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10939000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25004000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1730000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3868000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3375000
us-gaap Income Taxes Paid
IncomeTaxesPaid
986000
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
14962000
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
20508000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12657000
us-gaap Income Taxes Paid
IncomeTaxesPaid
55000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1511000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-5375000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 5.1%; vertical-align: top;"><div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">)</div></div></div> </td> <td style="width: 94.9%; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">RECENTLY ISSUED ACCOUNTING STATEMENTS</div></div></div> </td> </tr> </table> <div style=" margin: 0pt 15pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td colspan="7" style="width: 100%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following table provides a brief description of recent Accounting Standard Updates (&quot;ASU&quot;) issued by the FASB:</div> </td> </tr> <tr> <td style="width: 18.6%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 0.6%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 32.3%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 0.6%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 14.1%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 0.6%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 33.2%; vertical-align: bottom;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> </tr> <tr> <td style="width: 18.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Standard</div></div> </td> <td style="width: 0.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 32.3%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Description</div></div> </td> <td style="width: 0.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 14.1%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effective Date</div></div> </td> <td style="width: 0.6%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 33.2%; vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Effect on the Financial Statements or Other Significant Matters</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="width: 18.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> Leases.</div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 32.3%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The new guidance supersedes the lease guidance under FASB<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">840,</div> Leases, resulting in the creation of FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842,</div> Leases. The guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term for both finance and operating leases.</div></div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 14.1%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted.</div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 33.2%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is currently evaluating its population of leases, and is continuing to assess all potential impacts of the standard, but currently believes the most significant impact relates to its accounting for logistics equipment. The Company anticipates recognition of additional assets and corresponding liabilities related to leases upon adoption. The Company plans to adopt the standard effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019.</div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="width: 18.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Revenue from Contracts with Customers. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div></div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 32.3%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The core principle of this guidance is that an<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. To achieve the core principle, the guidance establishes the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> steps: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) identify the contract(s) with a customer, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) identify the performance obligation in the contract, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) determine the transaction price, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>) allocate the transaction price to the performance obligations in the contract, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also details the accounting treatment for costs to obtain or fulfill a contract. Lastly, disclosure requirements have been enhanced to provide sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.</div></div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 14.1%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Earlier adoption was permitted, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> before <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016.</div></div> </td> <td style="width: 0.6%; vertical-align: top;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> </td> <td style="width: 33.2%; vertical-align: top; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: none;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is in the process of evaluating the impact of this guidance.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;This new guidance,&nbsp;will likely&nbsp;result in a change in the nature and extent of the related footnote disclosures. The Company plans to adopt the new guidance when effective and presently anticipates adopting on a modified retrospective basis to each prior reporting period presented with the election of applicable practical expedients.</div></div> </td> </tr> </table></div>
CY2017Q3 us-gaap Distributed Earnings
DistributedEarnings
CY2016Q3 us-gaap Distributed Earnings
DistributedEarnings
8000
us-gaap Distributed Earnings
DistributedEarnings
us-gaap Distributed Earnings
DistributedEarnings
32000
CY2017Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
2625000
CY2016Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
110688000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.342
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.43
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.309
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.506
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2615000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
864000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-366000
us-gaap Gain Loss On Investments
GainLossOnInvestments
1457000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-145000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-147000
CY2017Q3 us-gaap Gross Profit
GrossProfit
5526000
CY2016Q3 us-gaap Gross Profit
GrossProfit
10319000
us-gaap Gross Profit
GrossProfit
13454000
us-gaap Gross Profit
GrossProfit
29344000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
177000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2184000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5064000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1425000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9853000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2780000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
219000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3081000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16333000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1181000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
21000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-22000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
84000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1587000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3565000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3220000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2735000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5546000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1185000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8570000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17009000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
128000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1760000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-37000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
413000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1152000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1104000
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
760000
us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
4009000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9519
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2263
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8748
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4694
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1408000
CY2017Q3 us-gaap Interest Expense
InterestExpense
43000
CY2016Q3 us-gaap Interest Expense
InterestExpense
45000
us-gaap Interest Expense
InterestExpense
129000
us-gaap Interest Expense
InterestExpense
130000
us-gaap Interest Expense Other
InterestExpenseOther
20000
us-gaap Interest Expense Other
InterestExpenseOther
20000
us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
2000
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18926000
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27971000
CY2017Q3 us-gaap Inventory Gross
InventoryGross
51769000
CY2016Q4 us-gaap Inventory Gross
InventoryGross
55011000
CY2017Q3 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
8246000
CY2016Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
2918000
CY2017Q3 us-gaap Inventory Net
InventoryNet
43523000
CY2016Q4 us-gaap Inventory Net
InventoryNet
52093000
CY2017Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
30797000
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
25127000
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2046000
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1913000
CY2017Q3 us-gaap Inventory Write Down
InventoryWriteDown
0
us-gaap Inventory Write Down
InventoryWriteDown
1912000
CY2016Q3 us-gaap Inventory Write Down
InventoryWriteDown
1877000
us-gaap Inventory Write Down
InventoryWriteDown
1877000
CY2017Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1965000
CY2016Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1637000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
5679000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
4446000
CY2017Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1965000
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1637000
us-gaap Investment Income Net
InvestmentIncomeNet
5679000
us-gaap Investment Income Net
InvestmentIncomeNet
4446000
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
876000
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1228000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3170000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3671000
CY2017Q3 us-gaap Liabilities
Liabilities
91856000
CY2016Q4 us-gaap Liabilities
Liabilities
196230000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
437571000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
529043000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
42206000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144049000
CY2017Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
49650000
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
52181000
CY2017Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2016Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1151000
CY2017Q3 us-gaap Marketable Securities
MarketableSecurities
110678000
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
100339000
CY2017Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
123588000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
106146000
CY2017Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
26000
CY2016Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-322000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-543000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-727000
us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; min-width: 700px;"> <tr> <td style="width: 4.5%; vertical-align: top;"><div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">)</div></div></div> </td> <td style="width: 95.4%; vertical-align: top;"> <div style=" margin: 0pt 0.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NATURE OF OPERATIONS AND BASIS OF PRESENTATION</div></div> </td> </tr> </table> <div style=" margin: 0pt 15pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Organization</div></div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">FutureFuel Corp. (&#x201c;FutureFuel&#x201d;), through its wholly-owned subsidiary, FutureFuel Chemical Company (&#x201c;FutureFuel Chemical&#x201d;), owns and operates a chemical production facility located on approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,200</div> acres of land <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> miles southeast of Batesville in north central Arkansas fronting the White River (the &#x201c;Batesville Plant&#x201d;). FutureFuel Chemical manufactures diversified chemical products, biobased products comprised of biofuels, and biobased specialty chemical products. FutureFuel Chemical<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s operations are reported in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> segments: chemicals and biofuels.</div></div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The chemicals segment manufactures a diversified portfolio of chemical products that are sold to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party customers. The majority of the revenues from the chemicals segment are derived from the custom manufacturing of specialty chemicals for specific customers.</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The biofuels business segment primarily produces and sells biodiesel. FutureFuel Chemical also sells petrodiesel in blends with the company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s biodiesel and, from time to time, with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> biodiesel added. Finally, FutureFuel Chemical is a shipper of refined petroleum products on common carrier pipelines and buys and sells petroleum products to maintain an active shipper status on these pipelines.</div></div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Basis</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style="display: inline; font-style: italic;">of</div> <div style="display: inline; font-style: italic;">Presentation</div></div></div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements have been prepared by FutureFuel in accordance and consistent with the accounting policies stated in FutureFuel<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> audited consolidated financial statements and should be read in conjunction with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> audited consolidated financial statements of FutureFuel.</div></div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 51pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">In the opinion of FutureFuel, all normal recurring adjustments necessary for a fair presentation have been included in the unaudited consolidated financial statements. The unaudited consolidated financial statements have been prepared in compliance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and with instructions to Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q adopted by the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, the financial statements do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all the information and footnotes required by GAAP for complete financial statements, and do include amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The unaudited consolidated financial statements include assets, liabilities, revenues, and expenses of FutureFuel and its wholly owned subsidiaries; namely, FutureFuel Chemical, FFC Grain, L.L.C., FutureFuel Warehouse Company, L.L.C., and Legacy Regional Transport, L.L.C. Intercompany transactions and balances have been eliminated in consolidation.</div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108215000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8111000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14252000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40444000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1542000
CY2017Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
477000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1668000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
2326000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1864000
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1159000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4890000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3258000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36440000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76879000
us-gaap Net Income Loss
NetIncomeLoss
7564000
us-gaap Net Income Loss
NetIncomeLoss
37661000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
3334000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
12868000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
2478000
us-gaap Operating Expenses
OperatingExpenses
7405000
us-gaap Operating Expenses
OperatingExpenses
7598000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3200000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7841000
us-gaap Operating Income Loss
OperatingIncomeLoss
6049000
us-gaap Operating Income Loss
OperatingIncomeLoss
21746000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
379000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
335000
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1467000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
669000
CY2017Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
123588000
CY2016Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
106146000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3839000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3876000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
26000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-322000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-543000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-727000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
17000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-210000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-353000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-472000
CY2017Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
9000
CY2016Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-112000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-190000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
-255000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1006000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1714000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
7102000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3741000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
653000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
882000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4612000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2199000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
353000
CY2016Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
505000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1562000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
832000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2490000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3396000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3325000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-84000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-117000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-331000
CY2017Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-101000
CY2016Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-478000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-789000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1188000
CY2017Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3331000
CY2016Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
12825000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
7549000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
37498000
CY2017Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3331000
CY2016Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
12825000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
7549000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
37498000
us-gaap Payments Of Dividends
PaymentsOfDividends
108063000
us-gaap Payments Of Dividends
PaymentsOfDividends
7869000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
121000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
59000
CY2015Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1408000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
25795000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
54096000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2614000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3107000
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
542000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1694000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
14913000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
20768000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111777000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
118152000
CY2017Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
38000
CY2016Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
57000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
138000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
146000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
935000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
688000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2535000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2113000
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1518000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
758000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
55746000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48182000
CY2017Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
500000
CY2016Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2413000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1039000
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
7881000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77606000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
69306000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
199765000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
183820000
us-gaap Share Based Compensation
ShareBasedCompensation
878000
us-gaap Share Based Compensation
ShareBasedCompensation
1431000
CY2017Q3 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
1072000
CY2016Q3 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
1306000
us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
2730000
us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
2871000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
345715000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
332813000
CY2017Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3000
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
35000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
15000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
131000
CY2017Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
3000
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
35000
CY2016 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
6844000
us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
921000
CY2016 us-gaap Unrealized Loss On Securities
UnrealizedLossOnSecurities
1037000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2052000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2056000
CY2017Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
248000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
193000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43714753
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
15000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
131000
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
13831000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43572997
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43671420
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43529423
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43705234
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43570734
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43662672
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43524729

Files In Submission

Name View Source Status
0001437749-17-018882-index-headers.html Edgar Link pending
0001437749-17-018882-index.html Edgar Link pending
0001437749-17-018882.txt Edgar Link pending
0001437749-17-018882-xbrl.zip Edgar Link pending
ex_98487.htm Edgar Link pending
ex_98488.htm Edgar Link pending
ex_98489.htm Edgar Link pending
ex_98490.htm Edgar Link pending
ff-20170930.xml Edgar Link completed
ff-20170930.xsd Edgar Link pending
ff-20170930_cal.xml Edgar Link unprocessable
ff-20170930_def.xml Edgar Link unprocessable
ff-20170930_lab.xml Edgar Link unprocessable
ff-20170930_pre.xml Edgar Link unprocessable
ff20170930_10q.htm Edgar Link pending
ff20170930_10qimg002.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending